Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PhRMA DTC Principles Compliance To Get Independent Panel Review In 2007

Executive Summary

PhRMA is giving itself one year to monitor member companies' implementation of its new direct-to-consumer "guiding principles" before an independent panel will begin analyzing compliance and progress

You may also be interested in...



PhRMA’s DTC Principles: After Two Years, Still A Work In Progress

According to recent polling, Americans have a reasonably favorable opinion of direct-to-consumer advertising, but the pharmaceutical industry still sees potential trouble based on how the public perceives the practice

PhRMA’s DTC Principles: After Two Years, Still A Work In Progress

According to recent polling, Americans have a reasonably favorable opinion of direct-to-consumer advertising, but the pharmaceutical industry still sees potential trouble based on how the public perceives the practice

Pfizer’s Lipitor Ad Campaign Is A Cautionary Tale For Industry

Controversy surrounding Pfizer's direct-to-consumer advertisements for Lipitor spotlight the inherent risks manufacturers continue to face when launching ad campaigns

Related Content

Topics

UsernamePublicRestriction

Register

PS046181

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel